Top Markets
Coin of the day
Johnson & Johnson Johnson & Johnson

Johnson & Johnson

JNJ
Hisse Senetlerindeki Sıralama #18
Johnson & Johnson, together with its subsidiaries, researches and develops,... Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Hisse Fiyatı
$240.45
Piyasa Değeri
$579.46B
Değişim (1 gün)
0.51%
Değişim (1 yıl)
46.88%
Ülke
US
Ticaret Johnson & Johnson (JNJ)

Kategori

Johnson & Johnson (JNJ) için kazanç
Dec 2025 itibarıyla kazanç TTM: $32.58B
Johnson & Johnson şirketinin en son finansal raporlarına göre, mevcut kazancı $32.58B'dir. 2024 yılında şirket $16.69B kazanç elde etti, bu 2023 yılındaki $15.06B kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Johnson & Johnson için kazanç geçmişi 2000 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $32.58B 0.00%
2025 $32.58B 95.25%
2024 $16.69B 10.79%
2023 $15.06B -21.46%
2022 $19.18B 16.25%
2021 $16.50B -4.80%
2019 $17.33B -3.73%
2018 $18.00B 1.84%
2017 $17.67B -10.76%
2016 $19.80B 3.16%
2015 $19.20B -6.65%
2014 $20.56B 32.91%
2013 $15.47B 12.31%
2012 $13.78B 11.44%
2011 $12.36B -27.06%
2010 $16.95B 7.57%
2009 $15.76B -6.93%
2008 $16.93B 27.45%
2007 $13.28B -8.94%
2006 $14.59B 11.22%
2005 $13.12B 6.37%
2004 $12.33B 19.63%
2003 $10.31B 10.95%
2002 $9.29B 17.64%
2001 $7.90B 15.00%
2000 $6.87B 0.00%
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
$25.73B -21.03%
US
$6.60B -79.75%
US
$16.35B -49.81%
CH
$12.40B -61.93%
GB
$21.07B -35.34%
US